202 related articles for article (PubMed ID: 22396785)
1. Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel.
Harley CA; Jesus CS; Carvalho R; Brito RM; Morais-Cabral JH
PLoS One; 2012; 7(3):e32654. PubMed ID: 22396785
[TBL] [Abstract][Full Text] [Related]
2. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
Gianulis EC; Trudeau MC
J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
[TBL] [Abstract][Full Text] [Related]
3. LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.
Stump MR; Gong Q; Zhou Z
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1397-404. PubMed ID: 23997099
[TBL] [Abstract][Full Text] [Related]
4. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
[TBL] [Abstract][Full Text] [Related]
5. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
[TBL] [Abstract][Full Text] [Related]
6. The mutation L69P in the PAS domain of the hERG potassium channel results in LQTS by trafficking deficiency.
Jenewein T; Kanner SA; Bauer D; Hertel B; Colecraft HM; Moroni A; Thiel G; Kauferstein S
Channels (Austin); 2020 Dec; 14(1):163-174. PubMed ID: 32253972
[TBL] [Abstract][Full Text] [Related]
7. Trafficking defects in PAS domain mutant Kv11.1 channels: roles of reduced domain stability and altered domain-domain interactions.
Ke Y; Ng CA; Hunter MJ; Mann SA; Heide J; Hill AP; Vandenberg JI
Biochem J; 2013 Aug; 454(1):69-77. PubMed ID: 23721480
[TBL] [Abstract][Full Text] [Related]
8. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
9. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation.
Chen J; Zou A; Splawski I; Keating MT; Sanguinetti MC
J Biol Chem; 1999 Apr; 274(15):10113-8. PubMed ID: 10187793
[TBL] [Abstract][Full Text] [Related]
10. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
Zhou Z; Gong Q; January CT
J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
[TBL] [Abstract][Full Text] [Related]
11. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
12. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
Paulussen A; Raes A; Matthijs G; Snyders DJ; Cohen N; Aerssens J
J Biol Chem; 2002 Dec; 277(50):48610-6. PubMed ID: 12354768
[TBL] [Abstract][Full Text] [Related]
14. An Interdomain KCNH2 Mutation Produces an Intermediate Long QT Syndrome.
Osterbur ML; Zheng R; Marion R; Walsh C; McDonald TV
Hum Mutat; 2015 Aug; 36(8):764-73. PubMed ID: 25914329
[TBL] [Abstract][Full Text] [Related]
15. [Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome].
Fang P; Lian J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):101-4. PubMed ID: 26829745
[TBL] [Abstract][Full Text] [Related]
16. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.
Roti EC; Myers CD; Ayers RA; Boatman DE; Delfosse SA; Chan EK; Ackerman MJ; January CT; Robertson GA
J Biol Chem; 2002 Dec; 277(49):47779-85. PubMed ID: 12270925
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block.
Rajamani S; Anderson CL; Anson BD; January CT
Circulation; 2002 Jun; 105(24):2830-5. PubMed ID: 12070109
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
Smith JL; Reloj AR; Nataraj PS; Bartos DC; Schroder EA; Moss AJ; Ohno S; Horie M; Anderson CL; January CT; Delisle BP
Am J Physiol Cell Physiol; 2013 Nov; 305(9):C919-30. PubMed ID: 23864605
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the LQT2-causing mutation R582C and the associated voltage-dependent fluorescence signal.
Fougere RR; Es-Salah-Lamoureux Z; Rezazadeh S; Eldstrom J; Fedida D
Heart Rhythm; 2011 Aug; 8(8):1273-80. PubMed ID: 21376840
[TBL] [Abstract][Full Text] [Related]
20. hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.
Trudeau MC; Leung LM; Roti ER; Robertson GA
J Gen Physiol; 2011 Dec; 138(6):581-92. PubMed ID: 22124116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
